BDNF and schizophrenia: Meta-analyses of clinical studies based on measurements of peripheral BDNF have reported significantly lower BDNF levels in patients with major depression, schizophrenia, bipolar disorder, or autism spectrum disorder (for meta-analyses see [25–28]).